Literature DB >> 6514284

Clinical experience and grading of amiodarone keratopathy.

R G Orlando, M E Dangel, S F Schaal.   

Abstract

Eighteen patients receiving the cardiac drug amiodarone were followed prospectively for the development of amiodarone keratopathy. Seventeen of 18 patients (94%) developed characteristic epithelial keratopathy in at least one eye within three months of the initiation of therapy. The pattern of the epithelial deposits was noted to undergo progressive changes in configuration as a function of the duration of amiodarone therapy. These evolving changes are well defined and allow development of a grading system for amiodarone keratopathy. A grading system as well as a proposed mechanism for evolving pattern of the keratopathy are presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514284     DOI: 10.1016/s0161-6420(84)34165-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy.

Authors:  Joanna Wasielica-Poslednik; Norbert Pfeiffer; Jörg Reinke; Susanne Pitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-01       Impact factor: 3.117

Review 2.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

3.  The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study.

Authors:  Karen Falke; Armin Büttner; Michael Schittkowski; Oliver Stachs; Robert Kraak; Andrey Zhivov; Arndt Rolfs; Rudolf Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-18       Impact factor: 3.117

4.  Amiodarone-induced multiorgan toxicity with ocular findings on confocal microscopy.

Authors:  Ugur Turk; Bengu Gerceker Turk; Suzan Guven Yılmaz; Esref Tuncer; Emin Alioğlu; Tugrul Dereli
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

5.  A novel mutation and in vivo confocal microscopic findings in Fabry disease.

Authors:  Cumali Degirmenci; Suzan Guven Yilmaz; Huseyin Onay; Melis Palamar; Sema Kalkan Ucar; Meral Kayikcioglu; Mahmut Coker
Journal:  Saudi J Ophthalmol       Date:  2017-01-03

6.  Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases.

Authors:  Joanna Wasielica-Poslednik; Giuseppe Politino; Irene Schmidtmann; Katrin Lorenz; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

7.  Retinal hyperreflective foci in Fabry disease.

Authors:  Yevgeniya Atiskova; Rahman Rassuli; Anja Friederike Koehn; Amir Golsari; Lars Wagenfeld; Marcel du Moulin; Nicole Muschol; Simon Dulz
Journal:  Orphanet J Rare Dis       Date:  2019-12-26       Impact factor: 4.123

Review 8.  Drug-induced corneal deposits: an up-to-date review.

Authors:  Jean-Yves Sahyoun; Saama Sabeti; Marie-Claude Robert
Journal:  BMJ Open Ophthalmol       Date:  2022-03-25

9.  In Vivo Confocal Microscopic Observations of Vortex Keratopathy in Patients with Amiodarone-Induced Keratopathy and Fabry Disease.

Authors:  Yasuhito Ikegawa; Atsushi Shiraishi; Yasuhito Hayashi; Akiyoshi Ogimoto; Yuichi Ohashi
Journal:  J Ophthalmol       Date:  2018-03-21       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.